Clinical labs report sharp declines in coronavirus molecular testing Adam Bonislawski, 360Dx Modern Healthcare Illustration / Getty Images NEW YORK – Over the last year, SARS-CoV-2 molecular testing has proved a boon for clinical labs, boosting their bottom lines even as routine testing volumes dropped during the pandemic. Recent financial reports from large national labs, however, show sharp declines in SARS-CoV-2 testing since the start of the year, indicating that this business is on the wane. During Labcorp's Q1 2021 earnings call this week, the company said that while it had averaged 1...